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Abstract
Background: Restriction of fat intake has been effective in improving insulin sensitivity in obese
and type 2 diabetic subjects, but what effects the recommended diet (less than 30% of total calories
from fat) have not been elucidated in subjects with type 2 diabetes. The purpose of this study was
to test the effects of oral fat challenge, composing 30% calories of a meal, on blood glucose, insulin,
lipid, leptin, plasminogen activator inhibitor-1 (PAI-1) and tumor necrosis factor-α (TNF-α).
Design and Methods: Blood glucose, insulin, lipid, leptin, TNF-α and PAI-1 were compared in 14
type 2 diabetic patients and 10 normal subjects after an oral fat challenge upto 2 hours (fasting, 15
min, 30 min, 45 min, 60 min, 90 min and 120 min).
Results: Postprandial glucose, total cholesterol, leptin, PAI-1 levels did not differ significantly from
levels at fasting. Serum triglyceride increased significantly from baseline only in diabetic patients (P
= 0.042). Serum insulin increased postprandially in both groups (P = 0.028 in diabetic group and P
= 0.055 in normal group), with displaying a prolonged insulin response in diabetic subjects. TNF-α
decreased postprandially in both groups without significant difference, although diabetic patients
have higher baseline levels (P = 0.024 compared to normal subjects).
Conclusions: Oral fat load does not have an acute effect on blood glucose, total cholesterol, leptin
and PAI-1 levels in both type 2 diabetic and normal subjects. TNF-α value showed decreased trend
in both diabetic and normal subjects. The tendency of a delayed postprandial insulin response and
elevated serum triglyceride level in diabetic subjects might be related to insulin resistance at the
level of adipose tissue. Additional research is needed to assess the impact of the use of fat contents
on the macronutrient composition of the diet, and potentially healthy and nutritional benefits for
patients with diabetes.
Introduction
The incidence of diabetes mellitus has been increasing
rapidly in the past 2 decades and this is accompanied by
the notably high prevalence of associated disorders, such
as hypertension, atherogenic lipid profile and metabolic
syndrome, which lead to significantly high cardiovascular
morbidity and mortality in diabetic patients. For reducing
the risk of developing cardiovascular disease in type 2 dia-
betic patients, there have been longstanding recommen-
dations to reduce saturated fat intake to <10% of energy
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intake and to limit total fat intake to <30% of total daily
calories. The study was to elucidate the effects of oral fat
challenge in stable type 2 diabetic subjects.
Research design and method
Subjects
There were 14 well controlled type 2 diabetic subjects
(hemoglobin A1c level below 7.5% for 6 months at least)
and 10 normal subjects enrolled in our study. All subjects
had normal renal and liver function profiles, and they had
no history of hyperlipidemia or thyroid disorders before.
All subjects had informed the study protocol and had
agreed for this study before and during study protocol.
Study protocol and procedure
In Eastern Asia, the average total calories intake was
around 1800 kcal in an average 60 kg subject. Dietary fat
intake was recommended to less than 30% of total daily
calories and average meal fat of each eating was around
180 kcal. In order to understand the effect of oral fat
intake in Chinese type 2 diabetic subjects and normal sub-
jects, we performed this study protocol in 2002.
After an overnight fast, an intravenous line was placed
into an antecubital vein for blood sampling and analysis.
All subjects received oral fat tolerance test by drinking 180
kcal of Lipovenos MCT 20% solution (Containing glyc-
erol 25 g, soybean oil 200 g and phosphatidylcholine 12
g in 1000 ml emulsion, Fresenius Kabi). Blood samples
were drawn at 0, 15, 30, 45, 60, 90 and 120 minutes.
Blood were collected under -20°C immediately and sent
for analyses later.
After completion of these tests, glucose, insulin, lipid pro-
files, plasminogen activator inhibitor 1 (PAI-1), leptin,
tumor necrosis factor-α (TNF-α) were analysed.
Biochemical analyses
Plasma glucose was measured using glucooxidase
method. Plasma insulin levels were determined by ELISA
method. Plasma samples were assayed for PAI-1 antigen
using colorimetric method (Sysmex CA-1500 and Beri-
chrom PAI reagent, Japan) and for leptin using RIA (radi-
oimmunoassay, LINCO Research Inc.) and TNF-α via EIA
(enzyme immunoassay, Immunotech Comp.) method.
Statistical analysis
Baseline data are expressed as means ± SD. All statistical
analyses were performed using the ANOVA test. Paired t
test or appropriate nonparametric tests were used to esti-
mate the effects of oral fat tolerance test on all variables.
All tests were conducted using an α level of 0.05.
Results
There were no significant differences on blood glucose
and cholesterol levels after oral fat challenge in both nor-
mal and type 2 diabetic subjects. (See figure 1) Concern-
ing blood triglyceride concentration, there was steady
increased triglyceride concentration and achieved signifi-
cantly statistical difference in type 2 diabetic subjects (P =
0.042). The insulin response showed early response in
normal subjects up to 45 minutes, but persistent response
with delayed returning to baseline value in type 2 diabetic
subjects. (See figure 2).
Type 2 diabetic subjects had higher values in baseline val-
ues of leptin and TNF-α, as compared with normal sub-
jects (TNF-α achieved significant difference as p = 0.024).
There were no significant differences in both normal and
type 2 diabetic subjects in leptin and TNF-α levels,
although it seemed to decline after oral fat challenge,
especially TNF-α in type 2 diabetic subjects (p = 0.12).
(See figure 3).
For PAI-1 response after oral fat challenge, there was no
statistical difference in normal and type 2 diabetic sub-
jects. The value of PAI-1 in type 2 diabetic subjects was
lower than normal subjects, although not statistically sig-
nificant. (probably due to ACE inhibitor usage in 8/14 sta-
ble diabetic subjects) [1]
Discussions
Prevention of chronic complications is a key issue in the
management of diabetes mellitus because of the huge pre-
mature morbidity and mortality associated with it. Recent
studies, the Finnish Diabetes Prevention Study [2] and the
Diabetes Prevention Program [3], strongly confirm the
hypothesis that alter diet and physical activity to achieve
weight loss can prevent or postpone the development of
type 2 diabetes in high-risk individuals.
In our study, there was no significant effect on blood glu-
cose, cholesterol, triglyceride, leptin, TNF-α and PAI-1 lev-
els up to 120 minutes in normal subjects, except showing
diminished TNF-α level trend (no significant difference, p
> 0.05). This means such oral intake of fat did not exert
abnormal response in normal subjects. In blood insulin
response, it displayed a peak response from 15 minutes to
45 minutes both in normal and type 2 diabetic subjects,
with delayed return to baseline level in type 2 diabetic
subjects. This response may be due to neural or hormonal
factors as insulin is also secreted in response to amino
acids and fatty acid with the magnitude of response being
modulated by a variety of neural and hormonal factors (as
glucagons, glucagons-like peptide 1, gastric inhibitory
polypeptide and somatostatin).Lipids in Health and Disease 2004, 3:17 http://www.lipidworld.com/content/3/1/17
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PAI-1, a member of the serine protease inhibitor family,
can promote both thrombosis and fibrosis that play a key
role in the pathogenesis of cardiovascular events. As these
cardiovascular events are increased in patients with diabe-
tes mellitus, it has been suggested that PAI-1 may be an
important culprit in diabetic vascular complications. Also
meal-related lipid excursions can potentially contribute to
the atherosclerosis in type 2 diabetic subjects via elevation
of variable inflammatory factors or cytokines, and several
factors can stimulate PAI-1 gene transcription and its
plasma levels, such as insulin [4], TNF-α [5], triglyceride
[6], glucose [7], and angiotensin II [8]. These suggest that
elevated plasma PAI-1 levels in type 2 diabetic patients are
associated with multiple components, as hyperglycemia,
hypertriglyceridemia, hyperinsulinemia and elevated
TNF-α, and substantially contribute to the prothrombotic
and proatherosclerotic processes. Our study revealed ele-
vated parameters in stable diabetic subjects as hyperglyc-
emia, hypertriglyceridemia, elevated TNF-α, and
hyperinsulinemia. The lower PAI-1 level in stable type 2
diabetic subjects as compared with normal subjects (2.50
IU/ml vs 3.07 IU/ml) was probably explained by ACE
inhibitor usage (8 in 14 diabetic patients), resulting
diminished angiotensin II formation. But this need fur-
ther studies to address this potentially important issue.
Moreover, there was no acute effect on blood leptin and
PAI-1 values in stable type 2 diabetic subjects after oral fat
challenge as shown in our study. The diminished TNF-α
level may be due to fat source (mainly polyunsaturated
fatty acid in our study), but it needed further evaluation to
The responses of glucose, cholesterol and triglyceride in normal and diabetic subjects after oral fat challenge Figure 1
The responses of glucose, cholesterol and triglyceride in normal and diabetic subjects after oral fat challenge. The triglyceride 
response showed significant difference in type 2 diabetic subjects as p value of 0.042. (N: normal subjects; DM: diabetic 
subjects)
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confirm this or to elucidate the impact of fat intake on
inflammatory factors on long-term effects of stable type 2
diabetic subjects or poorly controlled diabetic subjects.
Infusion of free fatty acids (as intralipid) causes increased
oxidative stress in the healthy [9] and the diabetic subjects
[10]. Simultaneously, elevated portal levels of FFA by oral
routine may impair liver function, causing increased glu-
coneogenesis, increased triglyceride production and
reduced insulin clearance, resulting in hyperglycemia,
dyslipidemia and hyperinsulinemia in type 2 diabetic
subjects. Also consumption of a high-fat diet and high
intakes of saturated fat are associated with an increased
risk of type 2 diabetes [11]. This means that both the total
amount and types of dietary fat play an important role in
insulin action, weight maintenance, and prevention of
diabetes. Thus it has lead to almost universal dietary rec-
ommendations to decrease the amount of dietary fat, aim-
ing for a total fat intake of no more than 30% of calories
and choosing foods low in saturated fat. It had been
reported that postprandial dyslipidemia (hypertriglyceri-
demia) has high correlation to coronary heart and/or
carotid artery disease [12-14] and may deterioate the insu-
lin resistance [15,16]. In our study, oral fat challenge
induces delayed postprandial insulin response and ele-
vated triglyceride level in stable type 2 diabetic subjects as
compared to normal subjects. It will be important when
recommending particular dietary source or pattern in the
management of medical nutrition therapy in diabetic sub-
jects to diminished postprandial hypertriglyceridemia.
However, the type of fat, rather than the amount of fat, in
the diet may be more important in terms of determining
health outcomes. As many studies had showed that the
The response of insulin in normal and diabetic subjects after oral fat challenge Figure 2
The response of insulin in normal and diabetic subjects after oral fat challenge. It showed persisted insulin response in diabetic 
subjects. (p = 0.028).
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long chain n-3 polyunsaturated fatty acid found in oily
fish and fish oil possessed cardioprotective effects [17,18]
and  α-lipoic acid possesses antioxidant property with
improving insulin sensitivity [19]. It is the future debate
about the relative effects of the importance of fat quality,
rather than fat quantity, in determining risk of developing
insulin resistance, obesity, metabolic syndrome and cardi-
ovascular disease.
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